UB17:LSE:LSE-UBS MSCI EMU Value UCITS EUR Adis (GBX)

ETF | Others |

Last Closing

USD 4351.75

Change

+53.50 (+1.24)%

Market Cap

N/A

Volume

228.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+2.45 (+0.98%)

USD 292,109.69B
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

+224.00 (+1.16%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

-2.75 (-1.41%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.04 (-0.24%)

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.05 (-0.38%)

USD 636.56B
0R1I:LSE NVIDIA Corp.

-1.80 (-1.51%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.15 (+0.22%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

-0.09 (-0.28%)

USD 260.39B
0QZO:LSE 0QZO

-0.40 (-0.40%)

USD 258.54B

ETFs Containing UB17:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.42% 94% A 90% A-
Dividend Return 0.01% 24% F 21% F
Total Return 18.43% 94% A 90% A-
Trailing 12 Months  
Capital Gain 16.95% 87% B+ 79% B-
Dividend Return 0.04% 29% F 26% F
Total Return 17.00% 86% B+ 78% C+
Trailing 5 Years  
Capital Gain 47.83% 40% F 49% F
Dividend Return 0.20% 27% F 33% F
Total Return 48.03% 37% F 47% F
Average Annual (5 Year Horizon)  
Capital Gain 8.59% 56% F 62% D
Dividend Return 8.60% 55% F 61% D-
Total Return 0.00% 19% F 12% F
Risk Return Profile  
Volatility (Standard Deviation) 12.21% 59% D- 75% C
Risk Adjusted Return 70.41% 68% D+ 80% B-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.